Page 52 - Revista Portuguesa - SPORL - Vol 60. Nº4

Acquir Immune Defic Syndr. 2014 Apr 15;65(5):603-10. doi:
10.1097/QAI.0000000000000083.
14. Rabinovics N, Mizrachi A, Hadar T, Ad-El D, Feinmesser
R, Guttman D. et. al. Cancer of the head and neck region
in solid organ transplant recipients. Head Neck. 2014
Feb;36(2):181-6. doi: 10.1002/hed.23283.
15. Takenaka Y, Oya R, Kitamiura T, Ashida N, Shimizu K,
Takemura K. et al. Platelet count and platelet-lymphocyte
ratio as prognostic markers for head and neck squamous
cell carcinoma: Meta-analysis. Head Neck. 2018
Dec;40(12):2714-2723. doi: 10.1002/hed.25366.
16. Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman
HW. The prognostic influence of tumour-infiltrating
lymphocytes in cancer: A systematic review with meta-
analysis. Br J Cancer. 2011 Jun 28;105(1):93-103. doi: 10.1038/
bjc.2011.189.
17. Tham T, Wotman M, Chung C, Ahn S, Dupuis H,
Gliagias V. et al. Systemic immune response in squamous
cell carcinoma of the head and neck: a comparative
concordance index analysis. Eur Arch Otorhinolaryngol.
2019 Oct;276(10):2913-2922. doi: 10.1007/s00405-019-
05554-x.
18. Saroul N, Puechmaille M, Lambert C, Hassan AS, Biau
J, Lapeyre M. et al. Prognosis in head and neck cancer:
importance of nutritional and biological inflammatory
status. Otolaryngol Head Neck Surg. 2022 Jan;166(1):118-
127. doi: 10.1177/01945998211004592.
19. Grivennikov SI, Greten FR, Karin M. Immunity,
Inflammation, and Cancer. Cell. 2010 Mar 19;140(6):883-99.
doi: 10.1016/j.cell.2010.01.025.
20. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG,
McMillan DC, Clarke SJ. The systemic inflammation-based
neutrophil-lymphocyte ratio: Experience in patients with
cancer. Crit Rev Oncol Hematol. 2013 Oct;88(1):218-30. doi:
10.1016/j.critrevonc.2013.03.010.
21. Du J, Liu J, Zhang X, Chen X, Yu R, Gu D. et al. Pre-
treatment neutrophil-to-lymphocyte ratio predicts
survival in patients with laryngeal cancer. Oncol Lett. 2018
Feb;15(2):1664-1672. doi: 10.3892/ol.2017.7501.
22. Tham T, Bardash Y, Herman SW, Costantino PD.
Neutrophil-to-lymphocyte ratio as a prognostic indicator
in head and neck cancer: a systematic review and meta-
analysis. Head Neck. 2018 Nov;40(11):2546-2557. doi:
10.1002/hed.25324.
23. Zhang X, Ran Y. Prognostic role of elevated platelet count
in patients with lung cancer: A systematic review and meta-
analysis. Int J Clin Exp Med. 2015 Apr 15;8(4):5379-87.
24. Men H, Liang C, Yu M. Thrombocytosis as a prognostic
factor in patients with renal cell carcinoma: a meta-analysis
of literature. J Cancer Res Ther. Jan-Mar 2015;11(1):67-72.
doi: 10.4103/0973-1482.150345.
25. Feng JF, Huang Y, Zhao Q, Chen QX. Clinical
significance of preoperative neutrophil lymphocyte ratio
versus platelet lymphocyte ratio in patients with small cell
carcinoma of the esophagus. ScientificWorldJournal. 2013
Sep 5;2013:504365. doi: 10.1155/2013/504365.

324 Revista Portuguesa de Otorrinolaringologia - Cirurgia de Cabeça e Pescoço